The lawsuit alleges that Nano-X misled shareholders by painting a picture of a robust, productive manufacturing facility in South Korea while failing to disclose that production was deeply misaligned with actual market demand. Throughout the period, the company’s SEC filings suggested the plant was fully capable of meeting anticipated needs, even as operating expenses and cash burn rates escalated behind the scenes.

On April 20, 2026, the company finally acknowledged the failure of its manufacturing strategy, announcing the closure of the Korean line and a pivot to outsourced production. This disclosure triggered the stock collapse, dropping shares to $2.155. Attorneys claim that by obscuring these rising costs and failing to account for the deteriorating value of its manufacturing assets, the company breached its obligations to provide an accurate picture of its financial health. Shareholders seeking to participate as lead plaintiffs in the recovery process must submit their applications by August 11, 2026.